A 6 Bp Polymorphism in the Thymidylate Synthase Gene Causes Message Instability and is Associated with Decreased Intratumoral TS MRNA Levels
Overview
Pharmacology
Authors
Affiliations
Objective: A 6 bp deletion polymorphism in the thymidylate synthase (TS) gene was investigated in order to determine its function.
Methods: A luciferase system was used to investigate the function of the 6 bp/1494 polymorphism in vitro. A group of 43 patients with colorectal carcinoma were evaluated for the 6 bp/1494 polymorphism and for intratumoral TS mRNA levels in vivo.
Results: The 3'UTR of TS containing the +6 bp polymorphism resulted in an approximate 35% decrease in luciferase activity and mRNA levels, while the TS-3'UTR bearing the -6 bp deletion resulted in an approximate 70% decrease in luciferase activity and mRNA levels. The TS-3'UTR construct containing the -6 bp/1494 deletion also had a higher rate of message degradation compared to the +6 bp/1494 construct. Individuals homozygous for the insertion (+6 bp/+6 bp) had significantly higher TS mRNA levels compared to individuals that were homozygous for the deletion (-6 bp/-6 bp) (P < 0.007). We determined the frequency of the -6 bp/1494 deletion polymorphism to be 41% in non-Hispanic whites, 26% in Hispanic whites, 52% in African-Americans and 76% in Singapore Chinese.
Conclusions: These results suggest that the -6 bp/1494 deletion polymorphism in the 3'UTR of TS is associated with decreased mRNA stability in vitro and lower intratumoral TS expression in vivo. Further, the 6 bp/1494 polymorphism varies greatly within different ethnic populations and is in linkage disequilibrium with the TS 5' tandem repeat enhancer polymorphism. Taken together, these data suggest that the 6 bp/1494 polymorphism may be a useful screening tool in predicting TS mRNA expression.
Understanding microRNA-Mediated Chemoresistance in Colorectal Cancer Treatment.
Valenzuela G, Contreras H, Marcelain K, Burotto M, Gonzalez-Montero J Int J Mol Sci. 2025; 26(3).
PMID: 39940936 PMC: 11818086. DOI: 10.3390/ijms26031168.
Mutlak Q, Kasim A, Aljanabi A Medicine (Baltimore). 2024; 103(23):e38448.
PMID: 38847705 PMC: 11155610. DOI: 10.1097/MD.0000000000038448.
Niknam M, Naghibalhossaini F, Zamani M, Hosseini S, Mokarram P Mol Biol Res Commun. 2024; 13(2):89-102.
PMID: 38504782 PMC: 10946552. DOI: 10.22099/mbrc.2023.48009.1850.
Yu F, Shi L, Wang Q, Xing X, Li Z, Hou L Biochem Genet. 2023; 62(1):468-484.
PMID: 37378701 PMC: 10901929. DOI: 10.1007/s10528-023-10431-8.
Raber I, Frazer M, Zerillo J, Asnani A JACC CardioOncol. 2021; 2(2):329-332.
PMID: 34396241 PMC: 8352086. DOI: 10.1016/j.jaccao.2020.04.005.